BIORESTORATIVE THERAPIES, INC. Other Significant Noncash Transaction, Value of Consideration Given
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Other Significant Noncash Transaction, Value of Consideration Given of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 · last filed 2014-05-14
- BIORESTORATIVE THERAPIES, INC. other significant noncash transaction, value of consideration given for the quarter ending 2014-03-31 was $0.00.
- BIORESTORATIVE THERAPIES, INC. other significant noncash transaction, value of consideration given for the quarter ending 2013-12-31 was $0.00.
- BIORESTORATIVE THERAPIES, INC. other significant noncash transaction, value of consideration given for the quarter ending 2013-09-30 was $0.00.
- BIORESTORATIVE THERAPIES, INC. other significant noncash transaction, value of consideration given for the quarter ending 2013-06-30 was $0.00.
- BIORESTORATIVE THERAPIES, INC. other significant noncash transaction, value of consideration given for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- BIORESTORATIVE THERAPIES, INC. other significant noncash transaction, value of consideration given for fiscal 2012 was $226.50K.
| Period end | Other Significant Noncash Transaction, Value of Consideration Given 3 month | Other Significant Noncash Transaction, Value of Consideration Given 6 month | Other Significant Noncash Transaction, Value of Consideration Given 9 month | Other Significant Noncash Transaction, Value of Consideration Given 12 month | Other Significant Noncash Transaction, Value of Consideration Given 54 month | Other Significant Noncash Transaction, Value of Consideration Given 57 month | Other Significant Noncash Transaction, Value of Consideration Given 60 month | Other Significant Noncash Transaction, Value of Consideration Given 63 month |
|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $226.50K 10-Q · filed 2014-05-14 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-11 | $0.00 derived: sum of 2 quarters · filed 2014-04-11 | $0.00 derived: sum of 3 quarters · filed 2014-04-11 | $0.00 10-K · filed 2014-04-11 | $226.50K 10-K · filed 2014-04-11 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | $0.00 derived: sum of 2 quarters · filed 2013-11-19 | $0.00 10-Q · filed 2013-11-19 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $226.50K 10-Q · filed 2013-11-19 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-19 | $0.00 10-Q · filed 2013-08-19 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $226.50K 10-Q · filed 2013-08-19 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | |||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-11 | $0.00 derived: sum of 2 quarters · filed 2014-04-11 | $226.50K 10-K · filed 2014-04-11 | |||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | $226.50K 10-Q · filed 2013-11-19 | ||||||
| 2012-06-30 | $226.50K 10-Q · filed 2013-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |